BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 20300788)

  • 1. Gluten T cell epitope targeting by TG3 and TG6; implications for dermatitis herpetiformis and gluten ataxia.
    Stamnaes J; Dorum S; Fleckenstein B; Aeschlimann D; Sollid LM
    Amino Acids; 2010 Nov; 39(5):1183-91. PubMed ID: 20300788
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TG6 Auto-Antibodies in Dermatitis Herpetiformis.
    Hadjivassiliou M; Reunala T; Hervonen K; Aeschlimann P; Aeschlimann D
    Nutrients; 2020 Sep; 12(9):. PubMed ID: 32967363
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intestinal TG3- and TG2-Specific Plasma Cell Responses in Dermatitis Herpetiformis Patients Undergoing a Gluten Challenge.
    Sankari H; Hietikko M; Kurppa K; Kaukinen K; Mansikka E; Huhtala H; Laurila K; Reunala T; Hervonen K; Salmi T; Lindfors K
    Nutrients; 2020 Feb; 12(2):. PubMed ID: 32069794
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The preferred substrates for transglutaminase 2 in a complex wheat gluten digest are Peptide fragments harboring celiac disease T-cell epitopes.
    Dørum S; Arntzen MØ; Qiao SW; Holm A; Koehler CJ; Thiede B; Sollid LM; Fleckenstein B
    PLoS One; 2010 Nov; 5(11):e14056. PubMed ID: 21124911
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dermatitis herpetiformis: a cutaneous manifestation of coeliac disease.
    Collin P; Salmi TT; Hervonen K; Kaukinen K; Reunala T
    Ann Med; 2017 Feb; 49(1):23-31. PubMed ID: 27499257
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Igs as Substrates for Transglutaminase 2: Implications for Autoantibody Production in Celiac Disease.
    Iversen R; Fleur du Pré M; Di Niro R; Sollid LM
    J Immunol; 2015 Dec; 195(11):5159-68. PubMed ID: 26503953
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhanced B-Cell Receptor Recognition of the Autoantigen Transglutaminase 2 by Efficient Catalytic Self-Multimerization.
    Stamnaes J; Iversen R; du Pré MF; Chen X; Sollid LM
    PLoS One; 2015; 10(8):e0134922. PubMed ID: 26244572
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elevation of IgA anti-epidermal transglutaminase antibodies in dermatitis herpetiformis.
    Hull CM; Liddle M; Hansen N; Meyer LJ; Schmidt L; Taylor T; Jaskowski TD; Hill HR; Zone JJ
    Br J Dermatol; 2008 Jul; 159(1):120-4. PubMed ID: 18503599
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transglutaminase 6 antibodies in the diagnosis of gluten ataxia.
    Hadjivassiliou M; Aeschlimann P; Sanders DS; Mäki M; Kaukinen K; Grünewald RA; Bandmann O; Woodroofe N; Haddock G; Aeschlimann DP
    Neurology; 2013 May; 80(19):1740-5. PubMed ID: 23576621
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibody Responses to Transglutaminase 3 in Dermatitis Herpetiformis: Lessons from Celiac Disease.
    Kaunisto H; Salmi T; Lindfors K; Kemppainen E
    Int J Mol Sci; 2022 Mar; 23(6):. PubMed ID: 35328331
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ex vivo Culture of Duodenal Biopsies from Patients with Dermatitis Herpetiformis Indicates that Transglutaminase 3 Antibody Production Occurs in the Gut.
    Hietikko M; Hervonen K; Ilus T; Salmi T; Huhtala H; Laurila K; Rauhavirta T; Reunala T; Kaukinen K; Lindfors K
    Acta Derm Venereol; 2018 Mar; 98(3):366-372. PubMed ID: 29182792
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transglutaminase 6 Antibodies in the Serum of Patients With Amyotrophic Lateral Sclerosis.
    Gadoth A; Nefussy B; Bleiberg M; Klein T; Artman I; Drory VE
    JAMA Neurol; 2015 Jun; 72(6):676-81. PubMed ID: 25867286
    [TBL] [Abstract][Full Text] [Related]  

  • 13. T Cell Response Toward Tissue-and Epidermal-Transglutaminases in Coeliac Disease Patients Developing Dermatitis Herpetiformis.
    Caproni M; Capone M; Rossi MC; Santarlasci V; Maggi L; Mazzoni A; Rossettini B; Renzi D; Quintarelli L; Bianchi B; Ninci A; Lami G; Calabrò A; Cosmi L; Annunziato F; Liotta F
    Front Immunol; 2021; 12():645143. PubMed ID: 33959126
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Missing Insight Into T and B Cell Responses in Dermatitis Herpetiformis.
    Kemppainen E; Salmi T; Lindfors K
    Front Immunol; 2021; 12():657280. PubMed ID: 33854513
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of Isopeptides Between Human Tissue Transglutaminase and Wheat, Rye, and Barley Gluten Peptides.
    Lexhaller B; Ludwig C; Scherf KA
    Sci Rep; 2020 May; 10(1):7426. PubMed ID: 32367038
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Dermatitis herpetiformis].
    Juratli HA; Görög A; Sárdy M
    Hautarzt; 2019 Apr; 70(4):260-264. PubMed ID: 30868254
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transglutaminases in autoimmune and inherited skin diseases: The phenomena of epitope spreading and functional compensation.
    Kárpáti S; Sárdy M; Németh K; Mayer B; Smyth N; Paulsson M; Traupe H
    Exp Dermatol; 2018 Aug; 27(8):807-814. PubMed ID: 28940785
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Separate Gut Plasma Cell Populations Produce Auto-Antibodies against Transglutaminase 2 and Transglutaminase 3 in Dermatitis Herpetiformis.
    Das S; Stamnaes J; Kemppainen E; Hervonen K; Lundin KEA; Parmar N; Jahnsen FL; Jahnsen J; Lindfors K; Salmi T; Iversen R; Sollid LM
    Adv Sci (Weinh); 2023 Sep; 10(25):e2300401. PubMed ID: 37424036
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dermatitis herpetiformis.
    Kárpáti S
    Clin Dermatol; 2012; 30(1):56-9. PubMed ID: 22137227
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Autoantibody binding and unique enzyme-substrate intermediate conformation of human transglutaminase 3.
    Heggelund JE; Das S; Stamnaes J; Iversen R; Sollid LM
    Nat Commun; 2023 Oct; 14(1):6216. PubMed ID: 37798283
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.